{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:29:11Z","timestamp":1791253751102,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ejpb.2018.08.014","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T09:24:54Z","timestamp":1535707494000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Spray congealed lipid microparticles for the local delivery of \u03b2-galactosidase to the small intestine"],"prefix":"10.1016","volume":"132","author":[{"given":"Serena","family":"Bertoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa Stella","family":"Dolci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Passerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.08.014_b0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2013.02.030","article-title":"Approaches for enhancing oral bioavailability of peptides and proteins","volume":"447","author":"Renukuntla","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.08.014_b0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.addr.2015.08.001","article-title":"Stabilization challenges and formulation strategies associated with oral biologic drug delivery systems","volume":"93","author":"Truong-Le","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.08.014_b0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijbiomac.2013.05.003","article-title":"The crystal structure of acidic \u03b2-galactosidase from Aspergillus oryzae","volume":"60","author":"Maksimainen","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2018.08.014_b0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/07388550903330497","article-title":"\u03b2 Galactosidases and their potential applications: a review","volume":"30","author":"Husain","year":"2010","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.ejpb.2018.08.014_b0025","first-page":"1","article-title":"Food Safety Authority (EFSA), Parma, Scientific Opinion on lactose thresholds in lactose intolerance and galactosaemia","volume":"8","author":"European","year":"2010","journal-title":"EFSA J."},{"key":"10.1016\/j.ejpb.2018.08.014_b0030","article-title":"Lactase non-persistence and lactose intolerance","volume":"19\u201323","author":"Bayless","year":"2017","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.ejpb.2018.08.014_b0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3748\/wjg.v12.i2.187","article-title":"Management and treatment of lactose malabsorption","volume":"12","author":"Montalto","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2018.08.014_b0040","first-page":"179","article-title":"Physicochemical characteristics of commercial lactases relevant to their application in the alleviation of lactose intolerance","volume":"134","author":"O\u2019Connell","year":"2006","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejpb.2018.08.014_b0045","unstructured":"C. Kim, H. Chung, M. Lee, L. Choi, M. Kim, Development of dried liposomes containing b-galactosidase for the digestion of lactose in milk 183 (1999) 185\u2013193."},{"key":"10.1016\/j.ejpb.2018.08.014_b0050","first-page":"234","article-title":"Formulation of enterosoluble microparticles for an acid labile protein","volume":"5","author":"Alavi","year":"2002","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.08.014_b0055","first-page":"153","article-title":"Microencapsulation of beta-galactosidase with Eudragit L-100","volume":"20","author":"Squillante","year":"2003","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2018.08.014_b0060","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/10717544.2014.905653","article-title":"Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of \u03b2-galactosidase","volume":"21","author":"Sheng","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.08.014_b0065","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/pat.3569","article-title":"Stable formulation of protein-type drug in electrospun polymeric fiber followed by tableting and scaling-up experiments","volume":"26","author":"Wagner","year":"2015","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.ejpb.2018.08.014_b0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.foodchem.2016.01.014","article-title":"Encapsulation of lactase (b-galactosidase) into k-carrageenan-based hydrogel beads: impact of environmental conditions on enzyme activity","volume":"200","author":"Zhang","year":"2016","journal-title":"Food Chem."},{"key":"10.1016\/j.ejpb.2018.08.014_b0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.foodhyd.2017.01.005","article-title":"Lactase (b-galactosidase) encapsulation in hydrogel beads with controlled internal pH microenvironments: impact of bead characteristics on enzyme activity","volume":"67","author":"Zhang","year":"2017","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.ejpb.2018.08.014_b0080","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/adfm.201202227","article-title":"Molecular sieving on the surface of a protein provides protection without loss of activity","volume":"23","author":"Liu","year":"2012","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejpb.2018.08.014_b0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00253-009-2270-7","article-title":"A novel acid-stable, acid-active b-galactosidase potentially suited to the alleviation of lactose intolerance","volume":"86","author":"O\u2019Connell","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejpb.2018.08.014_b0090","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s11095-015-1661-y","article-title":"Solvent-free melting techniques for the preparation of lipid-based solid oral formulations","volume":"32","author":"Becker","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.08.014_b0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejps.2012.02.021","article-title":"Spray congealed lipid microparticles with high protein loading: preparation and solid state characterisation","volume":"46","author":"Di Sabatino","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.08.014_b0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpharm.2014.04.055","article-title":"Formulating SLMs as oral pulsatile system for potential delivery of melatonin to pediatric population","volume":"469","author":"Albertini","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.08.014_b0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2016.08.024","article-title":"Development of microparticles for oral administration of the non-conventional radical scavenger IAC and testing in an in fl ammatory rat model","volume":"512","author":"Passerini","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.08.014_b0110","article-title":"In vitro lipolysis tests on lipid nanoparticles: comparison between lipase\/co-lipase and pancreatic extract In vitro lipolysis tests on lipid nanoparticles: comparison between lipase\/co-lipase and pancreatic extract","volume":"9045","author":"Jannin","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.08.014_b0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejpb.2015.04.027","article-title":"Chain length affects pancreatic lipase activity and the extent and pH \u2013 time profile of triglyceride lipolysis","volume":"93","author":"Benito-gallo","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.08.014_b0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/jphp.12182","article-title":"A simplified method to screen for in-vivo performance of oral lipid formulations","volume":"66","author":"Kilic","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.08.014_b0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0955-2863(92)90024-D","article-title":"Effects of droplet size, triacylglycerol composition, and calcium on the hydrolysis of complex emulsions by pancreatic lipase: an in vitro study","volume":"3","author":"Armand","year":"1992","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejpb.2018.08.014_b0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbalip.2008.05.006","article-title":"Lipolysis of the semi-solid self-emulsifying excipient Gelucire\u00ae 44\/14 by digestive lipases","volume":"1781","author":"Fernandez","year":"2008","journal-title":"Biochim. Biophys. Acta J."},{"key":"10.1016\/j.ejpb.2018.08.014_b0135","unstructured":"H.D. Williams, P. Sassene, K. Kleberg, J.B. Goma, M. Calderone, V. Jannin, A. Igonin, A. Partheil, D. Marchaud, E. Jule, J.A.N. Vertommen, R.I.C.C. E, A.M. Ullertz, J.H. Christopher, C.W. Pouton, Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1\u202f: method parameterization and comparison of in vitro digestion profiles across a range, J. Pharm. Sci. 101 (2012) 3360\u20133380."},{"key":"10.1016\/j.ejpb.2018.08.014_b0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5539\/ijc.v2n1p89","article-title":"Immobilization of \u03b2-galactosidase from Aspergillus Oryzae on Macroporous PloyGMA Newly Prepared","volume":"2","author":"Sun","year":"2010","journal-title":"Int. J. Chem."},{"key":"10.1016\/j.ejpb.2018.08.014_b0145","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.08.014_b0150","article-title":"Intestinal enzymatic metabolism of drugs","volume":"392\u2013399","author":"Sarti","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.08.014_b0155","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1211\/0022357056172","article-title":"Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release model","volume":"57","author":"Klein","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.08.014_b0160","doi-asserted-by":"crossref","unstructured":"P.C. Christophersen, L. Zhang, M. Yang, H.M. Nielsen, A. M\u00fcllertz, H. Mu, Solid lipid particles for oral delivery of pept. 1. Christophersen PC, Zhang L, Yang M, Nielsen HM, M\u00fcllertz A, Mu H. Solid lipid particles for oral delivery of peptide and protein drugs I \u2013 elucidating the release mechanism of lysozyme during lipolysis. Eu, Eur. J. Pharm. Biopharm. 85 (2013) 473\u2013480.","DOI":"10.1016\/j.ejpb.2013.07.017"},{"key":"10.1016\/j.ejpb.2018.08.014_b0165","article-title":"Solid lipid particles for oral delivery of peptide and protein drugs II \u2013 the digestion of trilaurin protects desmopressin from proteolytic degradation","volume":"1\u20139","author":"Christophersen","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.08.014_b0170","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2011.10.037","article-title":"Dissolution of solid lipid extrudates in biorelevant media","volume":"422","author":"Witzleb","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.08.014_b0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1211\/0022357021771896","article-title":"Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products","volume":"54","author":"Sek","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.08.014_b0180","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0005-2744(68)90078-8","article-title":"Substrate specificity of pancreatic lipase","volume":"159","author":"Brockerhoff","year":"1968","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.ejpb.2018.08.014_b0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4155\/tde.11.138","article-title":"Understanding the lipid-digestion processes in the GI tract before designing lipid-based drug-delivery systems","volume":"3","author":"N\u2019Goma Bakala","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2018.08.014_b0190","first-page":"241","article-title":"Purification and properties of beta-galactosidase from Aspergillus oryzae","volume":"77","author":"Tanaka","year":"1975","journal-title":"J. Biochem."},{"key":"10.1016\/j.ejpb.2018.08.014_b0195","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s11095-013-1233-y","article-title":"Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives","volume":"31","author":"Fuhrmann","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.08.014_b0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.chemphyslip.2008.11.002","article-title":"Characterization of the three major polymorphic forms and liquid state of tristearin by Raman spectroscopy","volume":"157","author":"Da Silva","year":"2009","journal-title":"Chem. Phys. Lipids."},{"key":"10.1016\/j.ejpb.2018.08.014_b0205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-5173(95)04286-5","article-title":"Crystallization tendency and polymorphic transitions in triglyceride nanoparticles","volume":"129","author":"Bunjes","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.08.014_b0210","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejpb.2007.09.011","article-title":"New spray congealing atomizer for the microencapsulation of highly concentrated solid and liquid substances","volume":"69","author":"Albertini","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.08.014_b0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2004.08.013","article-title":"Effect of Aerosil R on the properties of lipid controlled release microparticles","volume":"100","author":"Albertini","year":"2004","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2018.08.014_b0220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2007.02.008","article-title":"Influence of wettability and surface activity on release behavior of hydrophilic substances from lipid matrices","volume":"119","author":"Koennings","year":"2007","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2018.08.014_b0225","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.apsb.2014.09.001","article-title":"Pharmacokinetic aspects and in vitro \u2013 in vivo correlation potential for lipid-based formulations","volume":"4","author":"Kollipara","year":"2014","journal-title":"Acta Pharm. Sin. B."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118306763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118306763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T05:27:24Z","timestamp":1571808444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118306763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":45,"alternative-id":["S0939641118306763"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.08.014","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spray congealed lipid microparticles for the local delivery of \u03b2-galactosidase to the small intestine","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}